Does ERLOTINIB Cause Skin hyperpigmentation? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Skin hyperpigmentation have been filed in association with ERLOTINIB (Erlotinib). This represents 0.1% of all adverse event reports for ERLOTINIB.
16
Reports of Skin hyperpigmentation with ERLOTINIB
0.1%
of all ERLOTINIB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Skin hyperpigmentation From ERLOTINIB?
Of the 16 reports, 1 (6.3%) resulted in death, 1 (6.3%) required hospitalization.
Is Skin hyperpigmentation Listed in the Official Label?
Yes, Skin hyperpigmentation is listed as a known adverse reaction in the official FDA drug label for ERLOTINIB.
What Other Side Effects Does ERLOTINIB Cause?
Death (5,000)
Rash (4,648)
Diarrhoea (3,448)
Fatigue (1,548)
Nausea (1,366)
Drug ineffective (1,207)
Off label use (1,190)
Decreased appetite (998)
Malignant neoplasm progression (954)
Dry skin (953)
What Other Drugs Cause Skin hyperpigmentation?
ADAPALENE (2,811)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (2,277)
BIMATOPROST (189)
AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (182)
DUPILUMAB (177)
MINOCYCLINE (144)
LENALIDOMIDE (142)
METHOTREXATE (142)
CAPECITABINE (136)
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES (120)
Which ERLOTINIB Alternatives Have Lower Skin hyperpigmentation Risk?
ERLOTINIB vs ERTAPENEM
ERLOTINIB vs ERTUGLIFLOZIN PIDOLATE
ERLOTINIB vs ERYTHROMYCIN
ERLOTINIB vs ERYTHROMYCIN ETHYLSUCCINATE
ERLOTINIB vs ERYTHROMYCIN LACTOBIONATE